Cite
HARVARD Citation
Waalewijn, H. et al. (2022). Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Lancet. 9 (5), pp. e341-e352. [Online].